A genetic test known as chromosomal microarray analysis (CMA) could help identify the cause of sudden infant death syndrome (SIDS) or its counterpart in older children, known as sudden unexplained ...

A genetic test known as chromosomal microarray analysis (CMA) could help identify the cause of sudden infant death syndrome (SIDS) or its counterpart in older children, known as sudden unexplained ...

Genetic research labs are under constant pressure to increase their throughput while bringing down costs. Even though emerging new technologies can help labs expand their analysis capabilities, it’s ...

Thermo Fisher Scientific Inc., announced that the Applied Biosystems™ CytoScan™ Dx Assay and Applied Biosystems™ Chromosomal Analysis Suite (ChAS) Dx software now comply with In Vitro Diagnostic ...

(MENAFN- GlobeNewsWire - Nasdaq) Explore the booming Chromosomal Microarray Market, projected to grow from USD 1.69 Billion in 2025 to USD 3.32 Billion by 2034, at a 10.2% CAGR. Driven by demand for ...

Dublin, June 30, 2025 (GLOBE NEWSWIRE) -- The "Chromosomal Microarray Market Size, Share, Trends, Analysis, and Forecast 2025-2034 | Global Industry Growth, Competitive Landscape, Opportunities, and ...

FRAMINGHAM, Mass.--(BUSINESS WIRE)--Variantyx, a leader in genomic precision medicine, today announced the launch of its IriSight™ CNV Analysis - a whole genome-based test for the detection of ...

Genome sequencing is a comprehensive genetic test that is being integrated into health care systems internationally. Test indications include suspected genetic disorders in children and adults for ...

CARLSBAD, Calif.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, announced today that the Applied Biosystems™ CytoScan™ Dx Assay and Applied Biosystems™ ...